{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["berberine", "podocyte", "apoptosis", "palmitic acid", "endoplasmic reticulum stress"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33179098", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "30"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "12"}], "Language": ["eng"], "ELocationID": ["3", "10.3892/mmr.2020.11641"], "Journal": {"ISSN": "1791-3004", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan"}}, "Title": "Molecular medicine reports", "ISOAbbreviation": "Mol Med Rep"}, "ArticleTitle": "Berberine alleviates palmitic acid\u2011induced podocyte apoptosis by reducing reactive oxygen species\u2011mediated endoplasmic reticulum stress.", "Abstract": {"AbstractText": ["Lipid accumulation in podocytes can lead to the destruction of cellular morphology, in addition to cell dysfunction and apoptosis, which is a key factor in the progression of chronic kidney disease (CKD). Berberine (BBR) is an isoquinoline alkaloid extracted from medicinal plants such as <em>Coptis\u00a0chinensis</em>, which has been reported to have a lipid\u2011lowering effect and prevent CKD progression. Therefore, the present study aimed to investigate the effect of BBR on palmitic acid (PA)\u2011induced podocyte apoptosis and its specific mechanism using an <em>in\u00a0vitro</em> model. Cell death was measured using the Cell Counting Kit\u20118 colorimetric assay. Cell apoptotic rate was assessed by flow cytometry. The expression of endoplasmic reticulum (ER) stress\u2011 and apoptosis\u2011related proteins was detected by western blotting or immunofluorescence. Reactive oxygen species (ROS) were evaluated by 2',7'\u2011dichlorofluorescein diacetate fluorescence staining. The results of the present study revealed that BBR treatment decreased PA\u2011induced podocyte apoptosis. In addition, 4\u2011phenylbutyric acid significantly reduced PA\u2011induced cell apoptosis and the expression of ER stress\u2011related proteins, which indicated that ER stress was involved in PA\u2011induced podocyte apoptosis. In addition, N\u2011acetylcysteine inhibited PA\u2011induced excessive ROS production, ER stress and cell apoptosis of podocytes. BBR also significantly reduced PA\u2011induced ROS production and ER stress in podocytes. These results suggested that PA mediated podocyte apoptosis through enhancing ER stress and the production of ROS. In conclusion, BBR may protect against PA\u2011induced podocyte apoptosis, and suppression of ROS\u2011dependent ER stress may be the key mechanism underlying the protective effects of BBR."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China."}], "LastName": "Xiang", "ForeName": "Xing-Yang", "Initials": "XY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Chengdu Fifth People's Hospital, Chengdu, Sichuan 611130, P.R. China."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China."}], "LastName": "Wu", "ForeName": "Yue", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China."}], "LastName": "Jiang", "ForeName": "Xu-Shun", "Initials": "XS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands."}], "LastName": "He", "ForeName": "Jun-Ling", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Emergency Department, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China."}], "LastName": "Chen", "ForeName": "Xue-Mei", "Initials": "XM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China."}], "LastName": "Du", "ForeName": "Xiao-Gang", "Initials": "XG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Mol Med Rep", "NlmUniqueID": "101475259", "ISSNLinking": "1791-2997"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "2V16EO95H1", "NameOfSubstance": "Palmitic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Endoplasmic Reticulum Stress"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Regulatory Networks"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Palmitic Acid"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Podocytes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hager MR, Narla AD, Tannock LR. Dyslipidemia in patients with chronic kidney disease. Rev Endocr Metab Disord. 2017;18:29\u201340. doi: 10.1007/s11154-016-9402-z.", "ArticleIdList": ["10.1007/s11154-016-9402-z", "28000009"]}, {"Citation": "Keane WF, Tomassini JE, Neff DR. Lipid abnormalities in patients with chronic kidney disease: Implications for the pathophysiology of atherosclerosis. J Atheroscler Thromb. 2013;20:123\u2013133. doi: 10.5551/jat.12849.", "ArticleIdList": ["10.5551/jat.12849", "23095239"]}, {"Citation": "Kasiske BL, Wheeler DC. The management of dyslipidemia in CKD: New analyses of an expanding dataset. Am J Kidney Dis. 2013;61:371\u2013374. doi: 10.1053/j.ajkd.2012.11.035.", "ArticleIdList": ["10.1053/j.ajkd.2012.11.035", "23260277"]}, {"Citation": "Kowalski A, Krikorian A, Lerma EV. Dyslipidemia in chronic kidney disease. Dis Mon. 2015;61:396\u2013402. doi: 10.1016/j.disamonth.2015.07.004.", "ArticleIdList": ["10.1016/j.disamonth.2015.07.004", "26315102"]}, {"Citation": "Izquierdo-Lahuerta A, Martinez-Garcia C, Medina-G\u00f3mez G. Lipotoxicity as a trigger factor of renal disease. J Nephrol. 2016;29:603\u2013610. doi: 10.1007/s40620-016-0278-5.", "ArticleIdList": ["10.1007/s40620-016-0278-5", "26956132"]}, {"Citation": "Dai H, Liu Q, Liu B. Research progress on mechanism of podocyte depletion in diabetic nephropathy. J Diabetes Res. 2017;2017:2615286. doi: 10.1155/2017/2615286.", "ArticleIdList": ["10.1155/2017/2615286", "PMC5534294", "28791309"]}, {"Citation": "Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52:1031\u20131035. doi: 10.2337/diabetes.52.4.1031.", "ArticleIdList": ["10.2337/diabetes.52.4.1031", "12663476"]}, {"Citation": "Zhang Y, Ma KL, Liu J, Wu Y, Hu ZB, Liu L, Liu BC. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy. Am J Physiol Endocrinol Metab. 2015;308:E1140\u2013E1148. doi: 10.1152/ajpendo.00591.2014.", "ArticleIdList": ["10.1152/ajpendo.00591.2014", "25921580"]}, {"Citation": "Szeto HH, Liu S, Soong Y, Alam N, Prusky GT, Seshan SV. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int. 2016;90:997\u20131011. doi: 10.1016/j.kint.2016.06.013.", "ArticleIdList": ["10.1016/j.kint.2016.06.013", "27519664"]}, {"Citation": "Martinez-Garcia C, Izquierdo-Lahuerta A, Vivas Y, Velasco I, Yeo TK, Chen S, Medina-Gomez G. Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes. PLoS One. 2015;10:e0142291. doi: 10.1371/journal.pone.0142291.", "ArticleIdList": ["10.1371/journal.pone.0142291", "PMC4636358", "26545114"]}, {"Citation": "Xu S, Nam SM, Kim JH, Das R, Choi SK, Nguyen TT, Quan X, Choi SJ, Chung CH, Lee EY, et al. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress. Cell Death Dis. 2015;6:e1976. doi: 10.1038/cddis.2015.331.", "ArticleIdList": ["10.1038/cddis.2015.331", "PMC4670935", "26583319"]}, {"Citation": "Tao JL, Wen YB, Shi BY, Zhang H, Ruan XZ, Li H, Li XM, Dong WJ, Li XW. Endoplasmic reticulum stress is involved in podocyte apoptosis induced by saturated fatty acid palmitate. Chin Med J (Engl) 2012;125:3137\u20133142.", "ArticleIdList": ["22932195"]}, {"Citation": "Hua W, Huang HZ, Tan LT, Wan JM, Gui HB, Zhao L, Ruan XZ, Chen XM, Du XG. CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress. PLoS One. 2015;10:e0127507. doi: 10.1371/journal.pone.0127507.", "ArticleIdList": ["10.1371/journal.pone.0127507", "PMC4441449", "26000608"]}, {"Citation": "Rabbani GH, Butler T, Knight J, Sanyal SC, Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis. 1987;155:979\u2013984. doi: 10.1093/infdis/155.5.979.", "ArticleIdList": ["10.1093/infdis/155.5.979", "3549923"]}, {"Citation": "Taylor CE, Greenough WB., III Control of diarrheal diseases. Annu Rev Public Health. 1989;10:221\u2013244. doi: 10.1146/annurev.pu.10.050189.001253.", "ArticleIdList": ["10.1146/annurev.pu.10.050189.001253", "2655632"]}, {"Citation": "Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69\u201381. doi: 10.1016/j.jep.2014.09.049.", "ArticleIdList": ["10.1016/j.jep.2014.09.049", "25498346"]}, {"Citation": "Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10:1344\u20131351. doi: 10.1038/nm1135.", "ArticleIdList": ["10.1038/nm1135", "15531889"]}, {"Citation": "Ni WJ, Ding HH, Tang LQ. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms. Eur J Pharmacol. 2015;760:103\u2013112. doi: 10.1016/j.ejphar.2015.04.017.", "ArticleIdList": ["10.1016/j.ejphar.2015.04.017", "25912800"]}, {"Citation": "Zhang Z, Li B, Meng X, Yao S, Jin L, Yang J, Wang J, Zhang H, Zhang Z, Cai D, et al. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Sci Rep. 2016;6:20848. doi: 10.1038/srep20848.", "ArticleIdList": ["10.1038/srep20848", "PMC4746620", "26857750"]}, {"Citation": "Wang B, Xu X, He X, Wang Z, Yang M. Berberine improved aldo-induced podocyte injury via inhibiting oxidative stress and endoplasmic reticulum stress pathways both in vivo and in vitro. Cell Physiol Biochem. 2016;39:217\u2013228. doi: 10.1159/000445618.", "ArticleIdList": ["10.1159/000445618", "27336740"]}, {"Citation": "Jiang XS, Chen XM, Wan JM, Gui HB, Ruan XZ, Du XG. Autophagy protects against palmitic acid-induced apoptosis in podocytes in vitro. Sci Rep. 2017;7:42764. doi: 10.1038/srep42764.", "ArticleIdList": ["10.1038/srep42764", "PMC5320537", "28225005"]}, {"Citation": "Liu T, Chen XM, Sun JY, Jiang XS, Wu Y, Yang S, Huang HZ, Ruan XZ, Du XG. Palmitic acid-induced podocyte apoptosis via the reactive oxygen species-dependent mitochondrial pathway. Kidney Blood Press Res. 2018;43:206\u2013219. doi: 10.1159/000487673.", "ArticleIdList": ["10.1159/000487673", "29490300"]}, {"Citation": "Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: Autophagy induction, inhibition and selection. Autophagy. 2015;11:1956\u20131977. doi: 10.1080/15548627.2015.1091141.", "ArticleIdList": ["10.1080/15548627.2015.1091141", "PMC4824587", "26389781"]}, {"Citation": "Lukas J, Pospech J, Oppermann C, Hund C, Iwanov K, Pantoom S, Petters J, Frech M, Seemann S, Thiel FG, et al. Role of endoplasmic reticulum stress and protein misfolding in disorders of the liver and pancreas. Adv Med Sci. 2019;64:315\u2013323. doi: 10.1016/j.advms.2019.03.004.", "ArticleIdList": ["10.1016/j.advms.2019.03.004", "30978662"]}, {"Citation": "Maamoun H, Abdelsalam SS, Zeidan A, Korashy HM, Agouni A. Endoplasmic reticulum stress: A critical molecular driver of endothelial dysfunction and cardiovascular disturbances associated with diabetes. Int J Mol Sci. 2019;20:1658. doi: 10.3390/ijms20071658.", "ArticleIdList": ["10.3390/ijms20071658", "PMC6480154", "30987118"]}, {"Citation": "Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol. 2016;12:37\u201347. doi: 10.1038/nrneph.2015.180.", "ArticleIdList": ["10.1038/nrneph.2015.180", "26568191"]}, {"Citation": "Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J. Cholesterol metabolism in CKD. Am J Kidney Dis. 2015;66:1071\u20131082. doi: 10.1053/j.ajkd.2015.06.028.", "ArticleIdList": ["10.1053/j.ajkd.2015.06.028", "PMC4658227", "26337134"]}, {"Citation": "Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, et al. Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018;14:727\u2013749. doi: 10.1038/s41581-018-0072-9.", "ArticleIdList": ["10.1038/s41581-018-0072-9", "30361677"]}, {"Citation": "Reiser J, Sever S. Podocyte biology and pathogenesis of kidney disease. Annu Rev Med. 2013;64:357\u2013366. doi: 10.1146/annurev-med-050311-163340.", "ArticleIdList": ["10.1146/annurev-med-050311-163340", "PMC3736800", "23190150"]}, {"Citation": "Sieber J, Jehle AW. Free fatty acids and their metabolism affect function and survival of podocytes. Front Endocrinol (Lausanne) 2014;5:186. doi: 10.3389/fendo.2014.00186.", "ArticleIdList": ["10.3389/fendo.2014.00186", "PMC4209866", "25386168"]}, {"Citation": "Zou K, Li Z, Zhang Y, Zhang HY, Li B, Zhu WL, Shi JY, Jia Q, Li YM. Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2017;38:157\u2013167. doi: 10.1038/aps.2016.125.", "ArticleIdList": ["10.1038/aps.2016.125", "PMC5309756", "27917872"]}, {"Citation": "Cheng F, Wang Y, Li J, Su C, Wu F, Xia WH, Yang Z, Yu BB, Qiu YX, Tao J. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol. 2013;167:936\u2013942. doi: 10.1016/j.ijcard.2012.03.090.", "ArticleIdList": ["10.1016/j.ijcard.2012.03.090", "22465347"]}, {"Citation": "Saha SK, Khuda-Bukhsh AR. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: A mechanistic study including molecular docking. Eur J Pharmacol. 2014;744:132\u2013146. doi: 10.1016/j.ejphar.2014.09.048.", "ArticleIdList": ["10.1016/j.ejphar.2014.09.048", "25448308"]}, {"Citation": "Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93:2559\u20132565. doi: 10.1210/jc.2007-2404.", "ArticleIdList": ["10.1210/jc.2007-2404", "18397984"]}, {"Citation": "Wu U, Cha Y, Huang X, Liu J, Chen Z, Wang F, Xu J, Sheng L, Ding H. Protective effects of berberine on high fat-induced kidney damage by increasing serum adiponectin and promoting insulin sensitivity. Int J Clin Exp Pathol. 2015;8:14486\u201314492.", "ArticleIdList": ["PMC4713553", "26823767"]}, {"Citation": "Sun Y, Yuan X, Zhang F, Han Y, Chang X, Xu X, Li Y, Gao X. Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells. Sci Rep. 2017;7:11340. doi: 10.1038/s41598-017-11860-3.", "ArticleIdList": ["10.1038/s41598-017-11860-3", "PMC5595831", "28900305"]}, {"Citation": "Qin X, Zhao Y, Gong J, Huang W, Su H, Yuan F, Fang K, Wang D, Li J, Zou X, et al. Berberine protects glomerular podocytes via inhibiting Drp1-mediated mitochondrial fission and dysfunction. Theranostics. 2019;9:1698\u20131713. doi: 10.7150/thno.30640.", "ArticleIdList": ["10.7150/thno.30640", "PMC6485199", "31037132"]}, {"Citation": "Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev. 1999;13:1211\u20131233. doi: 10.1101/gad.13.10.1211.", "ArticleIdList": ["10.1101/gad.13.10.1211", "10346810"]}, {"Citation": "Begum G, Harvey L, Dixon CE, Sun D. ER stress and effects of DHA as an ER stress inhibitor. Transl Stroke Res. 2013;4:635\u2013642. doi: 10.1007/s12975-013-0282-1.", "ArticleIdList": ["10.1007/s12975-013-0282-1", "PMC3864671", "24323417"]}, {"Citation": "Gardner BM, Pincus D, Gotthardt K, Gallagher CM, Walter P. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb Perspect Biol. 2013;5:a013169. doi: 10.1101/cshperspect.a013169.", "ArticleIdList": ["10.1101/cshperspect.a013169", "PMC3578356", "23388626"]}, {"Citation": "Verfaillie T, Garg AD, Agostinis P. Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett. 2013;332:249\u2013264. doi: 10.1016/j.canlet.2010.07.016.", "ArticleIdList": ["10.1016/j.canlet.2010.07.016", "20732741"]}, {"Citation": "Chen Y, Wu Z, Zhao S, Xiang R. Chemical chaperones reduce ER stress and adipose tissue inflammation in high fat diet-induced mouse model of obesity. Sci Rep. 2016;6:27486. doi: 10.1038/srep27486.", "ArticleIdList": ["10.1038/srep27486", "PMC4897685", "27271106"]}, {"Citation": "Cabral-Miranda F, Hetz C. ER stress and neurodegenerative disease: A cause or effect relationship? Curr Top Microbiol Immunol. 2018;414:131\u2013157.", "ArticleIdList": ["28864830"]}, {"Citation": "Ariyasu D, Yoshida H, Hasegawa Y. Endoplasmic reticulum (ER) stress and endocrine disorders. Int J Mol Sci. 2017;18:382. doi: 10.3390/ijms18020382.", "ArticleIdList": ["10.3390/ijms18020382", "PMC5343917", "28208663"]}, {"Citation": "Cybulsky AV. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat Rev Nephrol. 2017;13:681\u2013696. doi: 10.1038/nrneph.2017.129.", "ArticleIdList": ["10.1038/nrneph.2017.129", "28970584"]}, {"Citation": "Szegezdi E, Fitzgerald U, Samali A. Caspase-12 and ER-stress-mediated apoptosis: The story so far. Ann N Y Acad Sci. 2003;1010:186\u2013194. doi: 10.1196/annals.1299.032.", "ArticleIdList": ["10.1196/annals.1299.032", "15033718"]}, {"Citation": "Coppolino G, Leonardi G, Andreucci M, Bolignano D. Oxidative stress and kidney function: A brief update. Curr Pharm Des. 2018;24:4794\u20134799. doi: 10.2174/1381612825666190112165206.", "ArticleIdList": ["10.2174/1381612825666190112165206", "30648504"]}, {"Citation": "Gai Z, Wang T, Visentin M, Kullak-Ublick GA, Fu X, Wang Z. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11:722. doi: 10.3390/nu11040722.", "ArticleIdList": ["10.3390/nu11040722", "PMC6520701", "30925738"]}, {"Citation": "Seervi M, Rani A, Sharma AK, Santhosh Kumar TR. ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine. Biomed Pharmacother. 2018;106:200\u2013209. doi: 10.1016/j.biopha.2018.06.123.", "ArticleIdList": ["10.1016/j.biopha.2018.06.123", "29960166"]}, {"Citation": "Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007;9:2277\u20132293. doi: 10.1089/ars.2007.1782.", "ArticleIdList": ["10.1089/ars.2007.1782", "17979528"]}, {"Citation": "Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014;21:396\u2013413. doi: 10.1089/ars.2014.5851.", "ArticleIdList": ["10.1089/ars.2014.5851", "PMC4076992", "24702237"]}, {"Citation": "Yu W, Sheng M, Xu R, Yu J, Cui K, Tong J, Shi L, Ren H, Du H. Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med. 2013;11:24. doi: 10.1186/1479-5876-11-24.", "ArticleIdList": ["10.1186/1479-5876-11-24", "PMC3599611", "23360542"]}, {"Citation": "Zhu L, Han J, Yuan R, Xue L, Pang W. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-\u03baB pathway. Biol Res. 2018;51:9. doi: 10.1186/s40659-018-0157-8.", "ArticleIdList": ["10.1186/s40659-018-0157-8", "PMC5878418", "29604956"]}, {"Citation": "Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, \u0160mejkal K, Malan\u00edk M, et al. Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics. 2019;9:1923\u20131951. doi: 10.7150/thno.30787.", "ArticleIdList": ["10.7150/thno.30787", "PMC6485276", "31037148"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "16"}, {"Year": "2020", "Month": "6", "Day": "22"}, {"Year": "2020", "Month": "11", "Day": "12", "Hour": "5", "Minute": "46"}, {"Year": "2020", "Month": "11", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33179098", "PMC7673344", "10.3892/mmr.2020.11641", "3"]}}]}